Anthropic Ventures into Drug Development with Claude Science
Le brief IA que les pros lisent chaque soir
Les 7 actus IA du jour, décryptées en 5 min. Gratuit.
Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.
Choisis ton rythme
Gratuit · Pas de spam · Désabonnement en 1 clic
During the event "The Briefing: AI for Science" held earlier this week, Anthropic made a major announcement with the launch of Claude Science. This new AI workspace is designed for scientists and aims to consolidate various tools and datasets that have been fragmented until now into a single coherent environment. The goal is to simplify the process of creating scientific figures and visuals.
Anthropic, which has already established itself as a key player in the AI field with its coding tools and powerful models, sees this initiative as an opportunity to significantly accelerate the pace of scientific discoveries. The company highlights the potential of AI to transform the development of health interventions, leveraging an impressive list of clients in the biotechnology and pharmaceutical sectors who are already using Claude.
But Anthropic is not stopping there. The company also announced its intention to develop its own medications. This move marks a significant step in the application of AI to medical research, with the hope of revolutionizing the way treatments are designed and brought to market.
Brief IA — L'actualité IA en français
L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.